Avaliação da disfunção hepática

Última revisión: 9 Aug 2025
Última actualización: 30 Jul 2025

Resumen

Diferenciales

Común

  • Infecção pelo vírus da hepatite C
  • Infecção pelo vírus da hepatite B
  • Infecção pelo vírus da hepatite A
  • Doença hepática relacionada ao álcool
  • Superdosagem de paracetamol
  • Outros medicamentos que não o paracetamol ou suplementos alimentares
  • Doença hepática gordurosa associada a disfunção metabólica
  • Síndrome de Gilbert
  • Hemocromatose
  • Coledocolitíase
Todos los datos

Infrecuente

  • Hepatite E
  • Hepatite D
  • Infecção por vírus Epstein-Barr
  • Infecção pelo vírus do herpes simples
  • Infecção por citomegalovírus
  • Infecção pelo vírus da imunodeficiência humana (HIV)
  • Sepse
  • Tuberculose extrapulmonar
  • Toxinas
  • Deficiência de alfa 1-antitripsina
  • Doença de Wilson
  • Hepatite autoimune
  • Colangite biliar primária
  • Colangite esclerosante primária
  • Carcinoma hepatocelular (CHC)
  • Metástases hepáticas
  • Câncer de pâncreas
  • Colangiocarcinoma
  • Linfoma de Hodgkin
  • Linfoma não Hodgkin
  • Choque
  • Trombose da veia porta
  • Síndrome de Budd-Chiari
  • Colestase intra-hepática gestacional
  • Síndrome HELLP (hemólise, enzimas hepáticas elevadas e plaquetopenia)
  • Esteatose hepática aguda da gravidez
Todos los datos

Colaboradores

Autores

Stevan A. Gonzalez, MD, MS

Professor

Department of Medicine

Burnett School of Medicine at TCU

Medical Director of Liver Transplantation

Annette C. and Harold C. Simmons Transplant Institute Fort Worth

Baylor Scott & White All Saints Medical Center Fort Worth

Fort Worth

TX

Divulgaciones

SAG declares that he has no competing interests.

Agradecimientos

Dr Stevan A. Gonzalez would like to gratefully acknowledge Dr Jeremy Cobbold, Dr William D. Carey, and Dr Achuthan Sourianarayanane, the previous contributors to this topic.

Divulgaciones

WDC is an author of a number of references cited in this topic. JC and AS declare that they have no competing interests.

Revisores por pares

Joseph K. Lim, MD

Assistant Professor of Medicine

Director

Yale Viral Hepatitis Program

Section of Digestive Diseases

Yale School of Medicine

New Haven

CT

Divulgaciones

JKL declares that he has no competing interests.

Philip Newsome, PhD, FRCPE

Senior Lecturer in Hepatology & Honorary Consultant Physician

Liver Research Group

Institute of Biomedical Research

The Medical School

University of Birmingham

Birmingham

UK

Divulgaciones

PN declares that he has no competing interests.

Marlyn Mayo, MD

Associate Professor of Medicine

Division of Digestive and Liver Diseases

University of Texas Southwestern Medical Center

Dallas

TX

Divulgaciones

MM is an author of a reference cited in this topic.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017 Jan;112(1):18-35. Resumen

Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-33.Texto completo

Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: alcohol-associated liver disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54.Texto completo  Resumen

Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023 Mar 1;77(3):1036-65.Texto completo

Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023 May 1;77(5):1797-835.Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Avaliação da disfunção hepática images
  • Guías de práctica clínica

    • EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
    • ACG clinical guideline: alcohol-associated liver disease
    Más Guías de práctica clínica
  • Folletos para el paciente

    Linfoma não Hodgkin

    Hepatite C: o que é?

    Más Folletos para el paciente
  • Calculadoras

    Escore de fibrose por DHGNA

    Más Calculadoras
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad